Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
Latest Information Update: 19 Jan 2024
At a glance
- Drugs Anti BCMA CAR T cell therapy-Carbiogene Therapeutics (Primary) ; Cyclophosphamide; Fludarabine
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 12 Dec 2023 Results presented at the 65th American Society of Hematology Annual Meeting and Exposition
- 02 Feb 2023 Planned primary completion date changed from 1 Oct 2022 to 1 Oct 2023.
- 04 Apr 2021 Status changed from not yet recruiting to recruiting.